Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1476

Showing 1-25 of 1476 citing articles:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1701
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1938-1952
Open Access | Times Cited: 556
Myocarditis
Cristina Basso
New England Journal of Medicine (2022) Vol. 387, Iss. 16, pp. 1488-1500
Closed Access | Times Cited: 108
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
Bettina Heidecker, Noa Dagan, Ran D. Balicer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 11, pp. 2000-2018
Open Access | Times Cited: 107
Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
Daniela Tomasoni, Gregg C. Fonarow, Marianna Adamo, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 431-441
Open Access | Times Cited: 105
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 98
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis
Jukka Lehtonen, Valtteri Uusitalo, Pauli Pöyhönen, et al.
European Heart Journal (2023) Vol. 44, Iss. 17, pp. 1495-1510
Open Access | Times Cited: 96
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
Marco Metra, Daniela Tomasoni, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 6, pp. 776-791
Open Access | Times Cited: 95
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
Kieran F. Docherty, Paul Welsh, Subodh Verma, et al.
Circulation (2022) Vol. 146, Iss. 13, pp. 980-994
Open Access | Times Cited: 91
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
Julio Núñez, Rafael de la Espriella, Patrick Rossignol, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1751-1766
Open Access | Times Cited: 89
Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Pieter Martens, Jeffrey M. Testani, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 603-619
Open Access | Times Cited: 88
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction
Marco Giuseppe Del Buono, Francesco Moroni, Rocco A. Montone, et al.
Current Cardiology Reports (2022) Vol. 24, Iss. 10, pp. 1505-1515
Open Access | Times Cited: 86
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
Antoni Bayés‐Genís, Kieran F. Docherty, Mark C. Petrie, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1891-1898
Open Access | Times Cited: 77
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis
Fraser J Graham, Pierpaolo Pellicori, Paul R. Kalra, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 4, pp. 528-537
Open Access | Times Cited: 74
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
Rebecca T. Hahn, Matthew Lawlor, Charles J. Davidson, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 17, pp. 1711-1735
Open Access | Times Cited: 74
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker, Muhammad Usman, Markus S. Anker, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 7, pp. 936-955
Open Access | Times Cited: 70
Mitral valve transcatheter edge-to-edge repair
Jörg Hausleiter, Thomas J. Stocker, Marianna Adamo, et al.
EuroIntervention (2023) Vol. 18, Iss. 12, pp. 957-976
Open Access | Times Cited: 62
Left Bundle Branch Area Pacing Versus Biventricular Pacing as Initial Strategy for Cardiac Resynchronization
Juan Carlos Díaz, William H. Sauer, Mauricio Duque, et al.
JACC. Clinical electrophysiology (2023) Vol. 9, Iss. 8, pp. 1568-1581
Open Access | Times Cited: 61
Cognitive Impairment in Patients With Cardiac Disease: Implications for Clinical Practice
Astrid C. van Nieuwkerk, Ronak Delewi, Frank J. Wolters, et al.
Stroke (2023) Vol. 54, Iss. 8, pp. 2181-2191
Closed Access | Times Cited: 46
The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
Jie Chen, Xiao‐Hong Wei, Qian Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 1919-1955
Open Access | Times Cited: 45
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction
Matteo Pagnesi, Marco Metra, Alain Cohen‐Solal, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 22, pp. 2131-2144
Open Access | Times Cited: 41
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial
Marianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, et al.
European Heart Journal (2023) Vol. 44, Iss. 31, pp. 2947-2962
Open Access | Times Cited: 40
Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis
Veronika A. Myasoedova, Valentina Parisi, Donato Moschetta, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Global epidemiology of heart failure
Muhammad Shahzeb Khan, Izza Shahid, Ahmed Bennis, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 10, pp. 717-734
Closed Access | Times Cited: 36
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top